| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 12 |
| NetGPI | no | yes: 0, no: 12 |
Related structures:
AlphaFold database: E9AMK7
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003676 | nucleic acid binding | 3 | 13 |
| GO:0003723 | RNA binding | 4 | 13 |
| GO:0005488 | binding | 1 | 13 |
| GO:0097159 | organic cyclic compound binding | 2 | 13 |
| GO:1901363 | heterocyclic compound binding | 2 | 13 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_PCSK_SKI1_1 | 23 | 27 | PF00082 | 0.273 |
| DOC_MAPK_gen_1 | 48 | 57 | PF00069 | 0.392 |
| DOC_USP7_MATH_1 | 87 | 91 | PF00917 | 0.442 |
| DOC_WW_Pin1_4 | 117 | 122 | PF00397 | 0.600 |
| DOC_WW_Pin1_4 | 2 | 7 | PF00397 | 0.469 |
| DOC_WW_Pin1_4 | 27 | 32 | PF00397 | 0.471 |
| LIG_14-3-3_CanoR_1 | 34 | 42 | PF00244 | 0.479 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.487 |
| LIG_CtBP_PxDLS_1 | 125 | 129 | PF00389 | 0.348 |
| LIG_eIF4E_1 | 123 | 129 | PF01652 | 0.466 |
| LIG_eIF4E_1 | 20 | 26 | PF01652 | 0.513 |
| LIG_FHA_1 | 6 | 12 | PF00498 | 0.405 |
| LIG_LIR_Apic_2 | 2 | 6 | PF02991 | 0.479 |
| LIG_LIR_Nem_3 | 27 | 32 | PF02991 | 0.449 |
| LIG_LYPXL_S_1 | 94 | 98 | PF13949 | 0.526 |
| LIG_LYPXL_yS_3 | 95 | 98 | PF13949 | 0.528 |
| LIG_SH2_CRK | 110 | 114 | PF00017 | 0.559 |
| LIG_SH2_CRK | 52 | 56 | PF00017 | 0.412 |
| LIG_SH2_SRC | 110 | 113 | PF00017 | 0.607 |
| LIG_SH2_SRC | 117 | 120 | PF00017 | 0.507 |
| LIG_SH2_STAT5 | 114 | 117 | PF00017 | 0.493 |
| LIG_SH2_STAT5 | 12 | 15 | PF00017 | 0.433 |
| LIG_SH3_3 | 106 | 112 | PF00018 | 0.558 |
| LIG_SH3_3 | 115 | 121 | PF00018 | 0.603 |
| LIG_SUMO_SIM_par_1 | 24 | 30 | PF11976 | 0.513 |
| MOD_CDK_SPxxK_3 | 2 | 9 | PF00069 | 0.450 |
| MOD_CDK_SPxxK_3 | 27 | 34 | PF00069 | 0.471 |
| MOD_CK1_1 | 124 | 130 | PF00069 | 0.436 |
| MOD_CK1_1 | 2 | 8 | PF00069 | 0.458 |
| MOD_CK1_1 | 74 | 80 | PF00069 | 0.475 |
| MOD_CK2_1 | 12 | 18 | PF00069 | 0.423 |
| MOD_GlcNHglycan | 104 | 107 | PF01048 | 0.375 |
| MOD_GlcNHglycan | 88 | 92 | PF01048 | 0.453 |
| MOD_GSK3_1 | 117 | 124 | PF00069 | 0.598 |
| MOD_GSK3_1 | 71 | 78 | PF00069 | 0.488 |
| MOD_Plk_2-3 | 18 | 24 | PF00069 | 0.510 |
| MOD_Plk_4 | 124 | 130 | PF00069 | 0.350 |
| MOD_ProDKin_1 | 117 | 123 | PF00069 | 0.602 |
| MOD_ProDKin_1 | 2 | 8 | PF00069 | 0.458 |
| MOD_ProDKin_1 | 27 | 33 | PF00069 | 0.471 |
| TRG_ENDOCYTIC_2 | 110 | 113 | PF00928 | 0.460 |
| TRG_ENDOCYTIC_2 | 123 | 126 | PF00928 | 0.565 |
| TRG_ENDOCYTIC_2 | 52 | 55 | PF00928 | 0.412 |
| TRG_ENDOCYTIC_2 | 95 | 98 | PF00928 | 0.498 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1HTR1 | Leptomonas seymouri | 87% | 99% |
| A0A1X0NNG9 | Trypanosomatidae | 59% | 100% |
| A0A3R7KCI5 | Trypanosoma rangeli | 59% | 100% |
| A0A3R7M619 | Trypanosoma rangeli | 30% | 79% |
| A0A3S5H6A7 | Leishmania donovani | 95% | 100% |
| A4H5I3 | Leishmania braziliensis | 89% | 100% |
| A4HTS4 | Leishmania infantum | 95% | 100% |
| D0A984 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 60% | 100% |
| P40565 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 25% | 89% |
| Q4QI29 | Leishmania major | 92% | 100% |
| V5BIJ7 | Trypanosoma cruzi | 62% | 100% |
| V5BSY3 | Trypanosoma cruzi | 38% | 66% |